LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Ovarian-Cancer Biomarker (HE4) Recognition in Serum Using Hetero TFET Biosensor

Photo from wikipedia

Recognition of ovarian-cancer biomarker (HE4) in serum using dual-material In0.53Ga0.47As/Si hetero-structure charge-plasma-based extended gate TFET biosensor (DCE-HTFET) has been depicted in this article. The virtual fabrication flow for the configuration… Click to show full abstract

Recognition of ovarian-cancer biomarker (HE4) in serum using dual-material In0.53Ga0.47As/Si hetero-structure charge-plasma-based extended gate TFET biosensor (DCE-HTFET) has been depicted in this article. The virtual fabrication flow for the configuration has been mentioned here. Silvaco ATLAS TCAD device simulator is used to optimize the device for better sensitivity. The sensitivity of the proposed model in the serum biosphere for different HE4 concentrations in histological subgroups of ovarian cancer has been investigated. An optimum ON-current to OFF-current sensitivity (SION/IOFF) of 18.2 × 106 and sensitivity regarding sub-threshold swing (SSS) of 95% have been achieved for the “Mucinous” type histological sub-group of ovarian-cancer biomarker having 74 pmol/L concentration. The proposed biosensor has been compared with the state-of-the-art literature to highlight its efficacy.

Keywords: serum; ovarian cancer; cancer biomarker; biosensor; cancer

Journal Title: IEEE Transactions on Nanotechnology
Year Published: 2023

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.